Interstitial Macrophages Mediate Efferocytosis of Alveolar Epithelium During Influenza Infection

Marilia Sanchez Santos Rizzo Zuttion,Tanyalak Parimon,Changfu Yao,Barry R Stripp,Ying Wang,Christopher M Soto,Zackary Ortega,Xiao Li,William J Janssen,Peter Chen,Christopher M. Soto,William J. Janssen
DOI: https://doi.org/10.1165/rcmb.2023-0217ma
IF: 7.748
2024-01-11
American Journal of Respiratory Cell and Molecular Biology
Abstract:Efferocytosis is a process whereby apoptotic cells are cleared to maintain tissue homeostasis. In the lungs, efferocytosis has been implicated in several acute and chronic inflammatory diseases. A long-standing method to study efferocytosis <i>in vivo</i> is to instill apoptotic cells into the lungs to evaluate macrophage uptake. However, this approach provides nonphysiologic levels of cells to the airspaces, where there is preferential access to the alveolar macrophages. To circumvent this limitation, we developed a new method to study efferocytosis of damaged alveolar type 2 (AT2) epithelial cells <i>in vivo</i>. A reporter mouse that expresses TdTomato in AT2 epithelial cells was injured with influenza (strain PR8) to induce apoptosis of AT2 cells. We were able to identify macrophages that acquire red fluorescence after influenza injury, indicating efferocytosis of AT2 cells. Furthermore, evaluation of macrophage populations led to the surprising finding that lung interstitial macrophages were the primary efferocyte <i>in vivo.</i> In summary, we present a novel finding that the interstitial macrophage, not the alveolar macrophage, primarily mediates clearance of AT2 cells in the lungs after influenza infection. Our method of studying efferocytosis provides a more physiologic approach in evaluating the spatiotemporal dynamics of apoptotic cell clearance <i>in vivo</i> and opens new avenues to study the mechanisms by which efferocytosis regulates inflammation.
biochemistry & molecular biology,cell biology,respiratory system
What problem does this paper attempt to address?